Page last updated: 2024-09-04

olmesartan and Bone Loss, Osteoclastic

olmesartan has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aoki, M; Kawahata, H; Moriguchi, A; Morishita, R; Nakagami, H; Ogihara, T; Sotobayashi, D; Yu, H	1

Other Studies

1 other study(ies) available for olmesartan and Bone Loss, Osteoclastic

Article	Year
Effect of angiotensin II receptor blocker, olmesartan, on turnover of bone metabolism in bedridden elderly hypertensive women with disuse syndrome. Geriatrics & gerontology international, 2015, Volume: 15, Issue:8 Topics: Age Distribution; Aged; Aged, 80 and over; Analysis of Variance; Angiotensin Receptor Antagonists; Bone Density; Bone Resorption; Calcium Channel Blockers; Cohort Studies; Female; Follow-Up Studies; Geriatric Assessment; Humans; Hypertension; Imidazoles; Immobilization; Incidence; Japan; Osteoporosis; Prognosis; Risk Assessment; Tetrazoles	2015

Article

Year

Effect of angiotensin II receptor blocker, olmesartan, on turnover of bone metabolism in bedridden elderly hypertensive women with disuse syndrome.

Geriatrics & gerontology international, 2015, Volume: 15, Issue:8

Topics: Age Distribution; Aged; Aged, 80 and over; Analysis of Variance; Angiotensin Receptor Antagonists; Bone Density; Bone Resorption; Calcium Channel Blockers; Cohort Studies; Female; Follow-Up Studies; Geriatric Assessment; Humans; Hypertension; Imidazoles; Immobilization; Incidence; Japan; Osteoporosis; Prognosis; Risk Assessment; Tetrazoles

2015